PABLO BANDERAS: Open Payments
NPI 1609868835 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,080 in 159 payments from 26 companies in 2025. Trend: 2023 $6,113 · 2024 $5,003 · 2025 $4,080
Food & beverage: $4,080
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 39 | $948 |
| AstraZeneca Pharmaceuticals LP | 14 | $655 |
| Lilly USA, LLC | 6 | $356 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $231 |
| ABBVIE INC. | 11 | $224 |
| PFIZER INC. | 9 | $190 |
| Lundbeck LLC | 11 | $155 |
| Corcept Therapeutics | 7 | $149 |
| Philips North America LLC | 6 | $140 |
| Esperion Therapeutics, Inc. | 6 | $134 |
Products named: AIRSUPRA, OTEZLA, EVENITY, KISUNLA, REPATHA, CAPLYTA, REXULTI, Korlym.
Industry payments across FL — which companies pay providers there.
